Immunophenotyping of Peripheral Blood Cells in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Chronic lymphocytic leukemia (CLL) is a B-cell-derived hematologic malignancy whose progression depends on active B-cell receptor (BCR) signaling. Despite the spectacular efficacy of Ibrutinib, an irreversible inhibitor of Bruton tyrosine kinase (BTK), resistance can develop in CLL patients, and alt...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Pierre Stéphan, Khaled Bouherrou, Yann Guillermin, Anne-Sophie Michallet, Yenkel Grinberg-Bleyer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-08-01
Sarja:	Cells
Aiheet:	chronic lymphocytic leukemia onco-immunology immunotherapy spectral flow cytometry
Linkit:	https://www.mdpi.com/2073-4409/13/17/1458
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!